Xinhua Wang

机构：Shanghai Jiao Tong University, Renji Hospital, Guangzhou University, First Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Bengbu Medical College, Io Therapeutics (United States), State Key Laboratory of Respiratory Disease, Guangzhou Medical University · ORCID：0000-0001-9118-3719

发表论文 118 篇 · 总被引 1586 次 · h-index 22

代表论文

• Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway (2024 · Gut · 被引 50)
• Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice (2022 · Journal of Ethnopharmacology · 被引 25)
• Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study (2025 · EP Europace · 被引 8)
• Efficacy and safety of bicyclol for treating patients with antituberculosis drug-induced liver injury (2024 · The International Journal of Tuberculosis and Lung Disease · 被引 8)
• NRF1 knockdown alleviates lipopolysaccharide-induced pulmonary inflammatory injury by upregulating DKK3 and inhibiting the GSK-3β/β-catenin pathway (2023 · Clinical & Experimental Immunology · 被引 7)
• Exploring the mechanism of Radix Bupleuri in the treatment of depression combined with SARS-CoV-2 infection through bioinformatics, network pharmacology, molecular docking, and molecular dynamic simulation (2025 · Metabolic Brain Disease · 被引 6)